Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
February 1, 2023

Mindpeak's PD-L1: First AI to be used in labs in Belgium to fight cancer

Mindpeak's PD-L1: First AI to be used in labs in Belgium to fight cancer

Ziekenhuis Netwerk Antwerpen (ZNA) and GZA Hospitals chose Mindpeak’s PD-L1 AI  to become the first lab in Belgium to use artificial intelligence in the fight against cancer.

Deeply integrated into the Telemis-platform, our AI helps their pathologists diagnose patients quicker and more reproducible by considering the complete tissue on images from biopsies and resectates - especially from the lung (PD-L1).

"With our AI, the matching of cancer patients to drugs can be significantly improved in clinical routine, which in turn greatly increases the chances of cure," says our founder and CEO Felix Faber.

Source

You may also be interested in

October 10, 2023
Mindpeak sets standards with PD-L1 Cell Atlas

A refined approach for AI-assisted cancer diagnosis was developed by setting standards in the interpretation of scoring guidelines with a "PD-L1 Cell Atlas".

Read more ⟶
Diagnostic throughput increased by up to 10x and more patients identified.

In a study investigating the efficiency gain in clinical routine with our AI Unilabs reported saving up to 90% diagnostic time compared to manual scoring. In addition, several patients needed to be re-classified leading to the identification of more patients eligible for treatment in the prospective study setting.

Read more ⟶
Poster HER2-low presented at ASCO2023

Our #ASCO2023 poster on HER2-low was selected for oral presentation by session chair Prof. David Rimm (Yale University School of Medicine). In his discussion he highlighted AI as an essential means to score HER2 in the future.

Read more ⟶

Find out more about our AI-based diagnostics

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mindpeak Breast IHC being displayed on a monitor

About Mindpeak

We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses.
‍
This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. Explainable AI (xAI) results provide the required trust of pathologists into our tools.

Company information

Local court Hamburg HRB 151143
‍
Managing director:
Felix Faber
‍
V.A.T. identification number:
DE318495606

Founded in 2018

Contact us

Mindpeak GmbH
Zirkusweg 2
20359 Hamburg
Germany
Email: info@mindpeak.ai
Telephone: +49 40 35 67 67 97

Regulatory Note:
Unless otherwise stated all products are intended for Research Use Only, not for use in diagnostic procedures.

© 2023 Mindpeak GmbH

Supported by:

Horizon 2020 (European Commission)

Privacy policy

Contact